Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

Background: Heart failure (HF) remains one of the leading causes of death to date despite
extensive research funding. Various studies are conducted every year in an attempt to …

This review summarizes the published literature referring to the use and validity of the
biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the …

Patients with severe aortic valve stenosis and concomitant pulmonary hypertension show a
significantly reduced survival prognosis. Right heart catheterization as a preoperative …

Peripheral arterial disease (PAD) is one of the most common manifestations of systemic
atherosclerosis. The prevalence of unrecognized PAD is high, leading to a lack of …

Aim Aim of our study was to evaluate metabolic changes in patients with aortic stenosis (AS)
before and after transcatheter aortic valve replacement (TAVR) and to assess whether this …

Background: Severe aortic valve stenosis (AS) is associated with pulmonary hypertension
(PH) and has been shown to limit patient survival. Soluble suppression of tumorigenicity-2 …

(1) Background: Currently, echocardiography is the primary non-invasive diagnostic method
used to screen patients with severe aortic valve stenosis (AS) for pulmonary hypertension …

Background: In contemporary clinical practice, there is an increasing need for new clinically
relevant biomarkers potentially optimizing management strategies in patients with suspected …

Background: Since right heart catheterization is rarely performed in patients with severe
aortic valve stenosis (AS), echocardiography is currently the tool of choice to determine the …